| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INCY | Common Stock | Options Exercise | $59,974 | +802 | +1.2% | $74.78 | 69,326 | 31 Jan 2023 | Direct | |
| transaction | INCY | Common Stock | Sale | $67,416 | -802 | -1.2% | $84.06 | 68,524 | 31 Jan 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -802 | -100% | $0.000000* | 0 | 31 Jan 2023 | Common Stock | 802 | $74.78 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| F2 | Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
| F3 | Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. |